Cargando…

Oral Vaccination Approaches for Anti-SHIV Immunity

We modified a Sabin Oral Poliovirus Vaccine (OPV) vector to permit secretion of the antigens of interest with the goal of improving anti-HIV Env humoral responses in a SHIV mucosal immunization composed of DNA and recombinant OPVs. We evaluated stimulation of systemic and mucosal cell-mediated and h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velarde de la Cruz, Erandi, Wang, Lingyun, Bose, Deepanwita, Gangadhara, Sailaja, Wilson, Robert L., Amara, Rama R., Kozlowski, Pamela A., Aldovini, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256843/ https://www.ncbi.nlm.nih.gov/pubmed/34234789 http://dx.doi.org/10.3389/fimmu.2021.702705

Ejemplares similares

V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques
por: Styles, Tiffany M., et al.
Publicado: (2022)

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
por: Jones, Andrew T., et al.
Publicado: (2019)

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
por: Arunachalam, Prabhu S., et al.
Publicado: (2020)

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
por: Charles, Tysheena P., et al.
Publicado: (2021)

Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques
por: Eudailey, Joshua A., et al.
Publicado: (2018)

Significant protection from infection and AIDS progression after gastrointestinal and oral vaccinations, respectively, with a SIV DNA/rMVA vaccine
por: Aldovini, A, et al.
Publicado: (2012)

Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques
por: Lu, Pinyi, et al.
Publicado: (2021)

Cytokine Adjuvants IL-7 and IL-15 Improve Humoral Responses of a SHIV LentiDNA Vaccine in Animal Models
por: Leroy, Laury-Anne, et al.
Publicado: (2022)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
por: Glenn, L. Lee
Publicado: (2013)

Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
por: Kozlowski, Pamela A., et al.
Publicado: (2022)

Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART(®) Molecules
por: Tuyishime, Marina, et al.
Publicado: (2021)

Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates
por: Dross, Sandra, et al.
Publicado: (2023)

Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge
por: Malherbe, Delphine C., et al.
Publicado: (2021)

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
por: Chamcha, Venkateswarlu, et al.
Publicado: (2016)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges
por: Gong, Siqi, et al.
Publicado: (2021)

Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
por: Lakhashe, Samir K., et al.
Publicado: (2022)

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
por: Sholukh, AM, et al.
Publicado: (2012)

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
por: Sholukh, Anton M, et al.
Publicado: (2014)

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins
por: Gangadhara, Sailaja, et al.
Publicado: (2017)

Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection
por: Curtis, Alan D., et al.
Publicado: (2022)

T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis
por: Kersh, Ellen N., et al.
Publicado: (2011)

Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates
por: Camp, Jeremy V., et al.
Publicado: (2021)

Vaccination-Induced Noncytolytic Effects in the Acute Phase of SHIV Infection
por: Petravic, Janka, et al.
Publicado: (2010)

GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
por: Robinson, H, et al.
Publicado: (2012)

OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV
por: Tangy, F, et al.
Publicado: (2009)

Lymph node CXCR5(+) NK cells associate with control of chronic SHIV infection
por: Rahman, Sheikh Abdul, et al.
Publicado: (2022)

Comparison of Systemic and Mucosal Immunization with Helper-Dependent Adenoviruses for Vaccination against Mucosal Challenge with SHIV
por: Weaver, Eric A., et al.
Publicado: (2013)

RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
por: Shao, Wei, et al.
Publicado: (2009)

Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
por: Weaver, Eric A., et al.
Publicado: (2009)

Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis
por: Zheng, Qi, et al.
Publicado: (2012)

Oral Vaccination of Fish – Antigen Preparations, Uptake, and Immune Induction
por: Mutoloki, Stephen, et al.
Publicado: (2015)

Tfh1 Cells in Germinal Centers During Chronic HIV/SIV Infection
por: Velu, Vijayakumar, et al.
Publicado: (2018)

Shiv Nadar School students visit CERN
por: Poulaillon, Jimmy, et al.
Publicado: (2023)

Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
por: Blasi, Maria, et al.
Publicado: (2020)

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge
por: Srivastava, Indresh K, et al.
Publicado: (2006)

Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
por: Vermaelen, Karim
Publicado: (2019)

Anti-Microbiota Vaccines Modulate the Tick Microbiome in a Taxon-Specific Manner
por: Mateos-Hernández, Lourdes, et al.
Publicado: (2021)

Anti-dengue Vaccines: From Development to Clinical Trials
por: Pinheiro-Michelsen, Josilene Ramos, et al.
Publicado: (2020)

Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4(+) T Cells
por: Obregon-Perko, Veronica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7q0k73aa9533ic7o3idc1fcudm